MWNA
AVAH icon

Marshall Wace North America’s Aveanna Healthcare AVAH Stock Holding History

Marshall Wace North America’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$550K Buy
+68,711
New +$666K ﹤0.01% 1094

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Marshall Wace North America's AVAH Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Aveanna Healthcare (AVAH) in Q3 2021: 68,711 shares worth $550K. The stake represents ﹤0.01% of the portfolio and ranks #1094 among its holdings.

87 funds tracked by Wall St. Rank hold AVAH as of Q3 2021.

  • Marshall Wace North America held 68,711 shares of Aveanna Healthcare worth $550K as of Q3 2021.
  • Aveanna Healthcare was a new Marshall Wace North America position in Q3 2021.
  • Aveanna Healthcare made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1094 holding.
  • 87 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.